Table 2.
Univariate and multivariate analyses for progression‐free survival
| Univariate | Multivariate | |||||
|---|---|---|---|---|---|---|
| P‐value | HR | 95%CI | P‐value | HR | 95%CI | |
| Age | ||||||
| ≤65 vs 65< | .5900 | 1.175 | 0.664‐2.196 | |||
| Gender | ||||||
| Male vs Female | .0259 | 0.546 | 0.313‐0.930 | .6472 | 0.828 | 0.365‐1.841 |
| Smoking | ||||||
| Never vs Ever | .0215 | 1.870 | 1.096‐3.252 | .8379 | 0.917 | 0.404‐2.100 |
| EGFR | ||||||
| Wild type vs Mutation | .0651 | 0.605 | 0.348‐1.032 | |||
| Grade | ||||||
| 1 vs 2‐3 | <.0001 | 3.380 | 1.923‐6.230 | .0647 | 1.772 | 0.966‐3.384 |
| pStage | ||||||
| pStage 0‐I vs pStage II‐IV | <.0001 | 9.485 | 5.488‐16.84 | <.0001 | 6.236 | 3.423‐11.60 |
| PD‐L1 | ||||||
| Negative vs Positive | <.0001 | 3.134 | 1.830‐5.341 | .0103 | 2.086 | 1.192‐3.635 |
| PD‐L2 | ||||||
| Negative vs Positive | .0006 | 0.388 | 0.216‐0.672 | .0823 | 0.594 | 0.321‐1.068 |
Italics indicates statistically significant.
Abbreviations: CI: confidential interval; HR: hazard ratio.